The present study showed that concentrations of FABPs except for FABP2 were correlated with distinct biochemical markers reflecting tissue damage in subjects on no medication: i.e., FABP1 for liver damage, FABP3 for cardiac injury, FABP4 for adiposity and metabolic syndrome, and FABP5 for adiposity, insulin resistance, cardiac injury, and liver damage. The gene discussed is FABP1; the disease is injury.